2m 2m 2m 2m 2m 2m 2m
KORRO BIO (KRRO)
NASDAQ
$9.67-$0.04 (-0.41%)
Price as of Oct 02, 2026 4:10 PM EDT- $143.0MMarket Cap
- -78.76%1-Year Change
- BiotechnologyIndustry
KORRO BIO (KRRO)
$9.67-$0.04 (-0.41%)
KRRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.71 | ||
Change | -$0.20 (-2.02%) | ||
Open | $9.93 | ||
High | $10.27 | ||
Low | $9.46 | ||
Previous Close | $9.91 | ||
Volume | 88,781 | ||
30-Day Average Volume | 193,379 | ||
1-Week Change | 1.46% | ||
1-Month Change | -20.67% | ||
1-Year Change | -78.76% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 14.7M | ||
Total Assets | $163.4M | ||
Market Cap | $143.0M | ||
Enterprise Value | $118.1M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$18.9M | ||
Free Cash Flow | -$17.0M | ||
EBIT | -$18.8M | ||
EBITDA | -$18.4M | ||
Net Working Capital | $108.0M | ||
EPS | -$1.07 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -9 | ||
PEG | -0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue